Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

KTOV RSS Feed
Add KTOV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/10/2019 11:38:18 AM - Followers: 116 - Board type: Free - Posts Today: 0




Kitov Pharma (KTOV)

Market Cap: $16 Million
Cash $17 Million
Price: $1.44

Shares Out: 10.6 Million


Kitov Announces FDA Acceptance of NDA for KIT-302..........October 3, 2017
https://www.baystreet.ca/articles/research_reports/lifesci/Kitov100317.pdf

KIT-302 is a Treatment for Hypertension and Osteoarthritis Pain.
KIT-302 is a fixed dose combination drug comprised of the nonsteroidal anti-inflammatory drug (NSAID)celecoxib, and the well-known antihypertensive agent, amlodipine besylate. Celecoxib monotherapy often leads to hypertension, which if uncontrolled, can increase the risk of heart attack and stroke. KIT-302 is designed to provide a solution for physicians who avoid prescribing NSAIDs for osteoarthritis pain due to their hypertensive side effects. There is currently no single drug for the treatment of pain and hypertension, so, if approved, KIT-302 could be a unique product in the multibillion-dollar osteoarthritis market.

Expected Upcoming Milestones

¦Additional marketing agreements for the distribution of KIT-302
¦Q4 2017 – Top-line results from Phase III kidney function trial.
¦Q2 2018 – Expected FDA approval decision for KIT-302.




Presentation June 2017
http://kitovpharma.investorroom.com/download/KitovPresentation+June+2017+FINAL.pdf

KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

Marketing potential Pipeline candidates address large, multi-billion dollar markets




Kitov Received a $2 Million Filing Waiver from FDA
http://kitovpharma.investorroom.com/news-releases?item=46

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302. KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously.

 

Products

Kitov’s current pipeline products, KIT-301 and KIT-302, are combination drugs that treat OA pain and HTN simultaneously. In December 2015, KIT-302 successfully achieved the primary efficacy endpoint for its Phase III clinical trial. In August 2016, the United States Patent Office issued a patent covering KIT-302.

Market

Of the 27 million Americans with OA, 50% also suffer from HTN, which is also a common side effect of stand-alone OA drugs. With no single medication currently treating both conditions, KIT-301 and KIT-302 are targeting this multi-billion dollar market.



Kitov Pharma’s Arthritis Drug Meets Main Goal in Late-Stage Study
http://jewishbusinessnews.com/2015/12/16/kitov-pharmas-arthritis-drug-meets-main-goal-in-late-stage-study/

“KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.





Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-reports-additional-data-from-its-phase-iii-trial-on-the-beneficial-blood-pressure-effects-of-kit-302-300194664.html



November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-holdings-announces-pricing-of-us-initial-public-offering-and-nasdaq-listing-552301701.html



October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302
http://www.prnewswire.com/news-releases/kitov-pharma-announces-completion-of-patient-recruitment-for-the-phase-iii-clinical-trial-for-kit-302-535035241.html





 

KTOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KTOV News: Report of Foreign Issuer (6-k) 05/16/2019 07:32:05 AM
KTOV News: Report of Foreign Issuer (6-k) 05/10/2019 04:04:50 PM
KTOV News: Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™ 05/10/2019 09:20:00 AM
KTOV News: Report of Foreign Issuer (6-k) 05/09/2019 04:09:03 PM
KTOV News: Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference 05/09/2019 08:30:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#6979   So now it’s 4th quarter launch? Wasn’t it zj3001 05/10/19 11:38:18 AM
#6978   Kitov Receives Notice of Allowance for Additional U.S. fwb 05/10/19 09:34:28 AM
#6977   All in LONG pre market!! beenfatt 05/10/19 09:23:12 AM
#6976   Oh dear, the only one reliable leaving the ship. finesand 05/02/19 05:07:05 PM
#6975   Kitov Announces Retirement of Founder and Executive Chairman fwb 05/02/19 04:54:05 PM
#6974   Jesus Christ you and LR Mods on IPIX!!! WTF tombrady12nh 04/30/19 10:20:12 AM
#6973   sadly so. Upcoming or ongoing funding until some finesand 04/25/19 09:39:35 AM
#6972   So Far KTOV has been a BUST..... fwb 04/24/19 11:08:17 AM
#6971   "wreaked"? Perhaps you mean "reeked" Leonard McKinley 04/17/19 07:24:47 AM
#6970   Means NOTHING CLDX had a Colab with BMY fwb 04/16/19 12:20:54 PM
#6969   I did like the premise of this company tykundegex 04/16/19 09:24:15 AM
#6968   Have you read the latest SA article in midastouch017 04/16/19 04:51:18 AM
#6967   Another Head Fake fwb 04/15/19 09:50:56 PM
#6966   good Volume beambe 04/13/19 03:46:59 AM
#6965   * * $KTOV Video Chart 04-12-2019 * * ClayTrader 04/12/19 05:01:19 PM
#6964   People selling after this news makes no sense JC$ 04/12/19 01:40:23 PM
#6963   Excellent news for KTOV ! JC$ 04/12/19 10:42:13 AM
#6962   News: $KTOV Kitov Announces Key Milestone in FameWave Acquisition whytestocks 04/12/19 10:21:01 AM
#6961   Boom 1.60 stock1ace1 04/12/19 10:15:15 AM
#6960   News: $KTOV FameWave Announces Clinical Collaboration with Bristol whytestocks 04/12/19 09:50:47 AM
#6959   Breaking 200 MA @$1.49 stock1ace1 04/12/19 09:26:17 AM
#6958   So I've pretty much lost everything on the LittleBytor 04/11/19 04:07:04 PM
#6957   VOTED AGAINST EVERYTHING fwb 04/06/19 07:43:25 PM
#6956   Last week was a head fake. fwb 03/25/19 08:16:26 PM
#6955   Potential Milestones Coming for Kitov Pharma and Product fwb 03/18/19 11:43:31 AM
#6954   In Here..She's gonna go.. jobilly 03/14/19 02:49:27 PM
#6953   News: $KTOV Kitov to Acquire Clinical Stage Candidate whytestocks 03/14/19 09:50:38 AM
#6952   News Kitov to Acquire Clinical Stage Candidate CM-24 Creating fwb 03/14/19 09:34:02 AM
#6951   Thanks for info. Doubletree 03/05/19 04:49:31 AM
#6950   You know you have to PAY an ADR FEE fwb 03/04/19 02:08:52 PM
#6949   Hi all, I am waiting up to it Doubletree 03/04/19 11:08:56 AM
#6948   Not ONLY is KTOV NOT doing anything fwb 03/01/19 02:19:26 PM
#6947   I am still hopefull. KTOV midastouch017 02/26/19 03:26:34 AM
#6946   Keep your fingers cross for KTOV while you fwb 02/25/19 03:20:06 PM
#6943   Figers crossed for you. I do not look midastouch017 01/31/19 06:04:28 AM
#6942   Sorry to hear that.....I’m still convinced by the Locke1 01/30/19 03:11:26 PM
#6941   Sold all my holdings with a loss. I midastouch017 01/30/19 12:35:25 PM
#6940   Are you still in $RHDL? Nice action recently.....???? Locke1 01/30/19 12:00:20 PM
#6939   No pm activities in TASE. HOD price so midastouch017 01/27/19 05:17:15 AM
#6938   Yes. Do you see any pm activities so Locke1 01/27/19 01:16:12 AM
#6937   Let's see what TASE will say today! midastouch017 01/27/19 12:43:40 AM
#6936   Interesting trading session yesterday. Some big blocks were Locke1 01/26/19 04:19:38 AM
#6935   You are right, I wouldn't believe them. jdlamont 01/25/19 09:20:22 AM
#6934   Not everyone needs reassurance. And, if they nsomniyak 01/24/19 02:29:25 PM
#6933   company is bunch of thug liars. Stock jdlamont 01/24/19 09:45:49 AM
#6932   Nice. Volume also decent. Looking forward to tomorrow’s Locke1 01/21/19 11:05:51 AM
#6931   Nice action in TASE/KTOV today. +15.5% now, price midastouch017 01/21/19 07:34:33 AM
#6930   Thanks for playing but you had nothing to Slax 01/19/19 05:57:40 PM
#6929   KTOV buy 1.3400 stocktrademan 01/18/19 12:07:41 PM
#6928   Very thorough SA article published today. :-) midastouch017 01/18/19 01:04:45 AM
PostSubject